This is a type of lymphoma that starts in T-cells, which are a specific kind of white blood cell. It's a group of different related cancers that affect the immune system.
Every report comes from a Lived member, sent anonymously.
Have you had Chemotherapy infusion for T-Cell Lymphoma?
T-cell lymphoma is a cancer that starts in T cells (also called T lymphocytes), white blood cells that help direct the immune system. When T cells become abnormal and keep dividing, they can build up in lymph nodes and in other places such as the skin, spleen, liver, bone marrow or intestines. It is one of the two main families of non-Hodgkin lymphoma. The other, much more common family starts in B cells. T-cell lymphoma is an umbrella term for many different diseases, each of them rare. Together they make up less than 15% of non-Hodgkin lymphomas in the United States. They include lymphomas that start in the skin (such as mycosis fungoides), a fast-growing type that mostly affects teens and young adults (T-lymphoblastic lymphoma), and a larger group called peripheral T-cell lymphomas, which develop from more mature T cells. Here "peripheral" means the cancer arises in lymph tissue outside the bone marrow, not in the hands or feet. Common peripheral types include peripheral T-cell lymphoma not otherwise specified, angioimmunoblastic T-cell lymphoma and anaplastic large cell lymphoma. Most of them grow quickly, and the exact type shapes nearly every later decision about treatment and outlook. Symptoms depend on where the lymphoma is. Many people notice painless swollen lymph nodes in the neck, armpit or groin, or tiredness that does not lift. Some have what doctors call B symptoms: fevers without an infection, drenching night sweats, and weight loss without trying of at least 10% of body weight over 6 months. Depending on the type, there may also be skin rashes or lumps, an enlarged spleen or liver, belly pain, or frequent infections.
Most people with T-cell lymphoma have no identifiable cause. The disease begins when changes in a T cell's genes let it grow out of control, but what sets off those changes is usually unknown. Having a risk factor does not mean someone will develop lymphoma, and many people who do have no known risk factors. A few links are clear for particular types. Adult T-cell leukemia/lymphoma is caused by long-term infection with HTLV-1 (human T-cell lymphotropic virus type 1), a virus that spreads through sex, blood and breastfeeding and is far more common in Japan, the Caribbean and parts of Africa than in the United States. Enteropathy-associated T-cell lymphoma, which forms in the lining of the intestine, develops in some people with celiac disease, mostly those diagnosed with celiac disease as adults. Extranodal NK/T-cell lymphoma, which arises from T cells or closely related natural killer (NK) cells and usually affects the nose and upper throat, is more common in parts of Asia and South America. A rare form of anaplastic large cell lymphoma can grow in the scar tissue around breast implants, more often with textured implants. Broader risk factors for non-Hodgkin lymphoma also apply: older age, male sex, a weakened immune system (for example after an organ transplant or with HIV) and some autoimmune diseases. These raise risk across many lymphoma types and do not explain why any one person became ill.
A biopsy is the only way to confirm lymphoma. Because the exact type matters so much, doctors usually remove a whole lymph node or a sizable piece of tissue (an excisional or incisional biopsy) rather than relying on a thin-needle sample, which may not hold enough cells to name the type. In the lab, the tissue is tested with antibodies that stick to specific proteins on cells (immunohistochemistry and flow cytometry). This shows whether the cancer cells are T cells, which type of T-cell lymphoma they form, and whether they carry markers that affect treatment. Two matter especially: CD30, a protein that one of the main drugs targets, and ALK, a protein whose presence in anaplastic large cell lymphoma points to a better outlook. Chromosome and DNA tests on the sample can add further detail. Once the diagnosis is made, staging shows how far the lymphoma has spread. This usually involves blood tests and imaging, often a PET/CT scan, which pairs a detailed computed tomography (CT) image with a positron emission tomography (PET) scan that highlights very active cells. A bone marrow biopsy may be done to see whether the lymphoma has reached the marrow, the soft inner part of bones where blood cells are made.
Treatment depends heavily on the type and stage, so the plan for one T-cell lymphoma can look nothing like the plan for another. Lymphomas that start in the skin, such as mycosis fungoides, follow a separate treatment approach. T-lymphoblastic lymphoma is treated like acute lymphoblastic leukemia, with intensive combinations of chemotherapy that often begin in the hospital, chemotherapy into the spinal fluid to protect the brain and spinal cord, and sometimes ongoing maintenance treatment for up to 2 years. For most peripheral T-cell lymphomas, the first treatment is combination chemotherapy given in cycles, with rest periods so the body can recover. A common regimen is CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone), sometimes with etoposide added. For anaplastic large cell lymphoma, and for other types whose cells carry CD30, an alternative replaces vincristine with brentuximab vedotin (Adcetris), an antibody that delivers a chemotherapy drug directly to cells displaying CD30. Radiation may be added when the lymphoma is limited to one area. Many peripheral T-cell lymphomas respond to this first treatment but come back later. For that reason, people who are well enough are often offered high-dose chemotherapy followed by a transplant of their own blood-forming stem cells once the lymphoma is in remission, to lower the chance of relapse. If the lymphoma returns, other chemotherapy, targeted drugs or a stem cell transplant from a donor may be options. Because standard treatments have real limits, taking part in a clinical trial is often a reasonable choice at any stage. Some types follow their own path. Breast implant-associated anaplastic large cell lymphoma is usually treated by removing the implant and the scar tissue around it. The slow-growing smoldering and chronic forms of adult T-cell leukemia/lymphoma can often be watched without treatment at first, and when treatment is needed, antiviral medicine is one option. Intestinal T-cell lymphoma may need surgery, partly because the bowel wall can tear as the tumor shrinks during treatment.
The outlook varies more by type than with many cancers. Anaplastic large cell lymphoma, especially the ALK-positive form, often responds well, and many people are cured. T-lymphoblastic lymphoma also has a good chance of cure when it has not spread to the bone marrow at diagnosis. Other peripheral types, such as peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma, often shrink with the first treatment but tend to return and become harder to treat, so the plan may unfold in several stages and the outlook is more guarded. The slow forms of adult T-cell leukemia/lymphoma can stay stable for long periods. Chemotherapy cycles each last several weeks and usually continue for some months. Common effects include tiredness, nausea, hair loss, mouth sores and lower blood counts, which raise the risk of infection and easy bruising. Medicines can prevent or ease nausea, and doses may be adjusted if side effects become serious. Many people need to scale back work and other commitments during treatment, and a stem cell transplant adds a further intensive phase and recovery. Scans during and after treatment show how well it is working. After treatment ends, follow-up visits are usually every few months for the first year or so and then less often. They check for any return of the lymphoma, which can occasionally happen years later, and for long-term effects of treatment.
See a doctor if a swollen lymph node does not go away, or if you have unexplained fevers, drenching night sweats or weight loss without trying. Most swollen nodes turn out to be caused by infection, but persistent ones are worth checking. During chemotherapy, a fever of 100.5°F (38°C) or higher, chills or other signs of infection need a call to your cancer care team right away, because infections during treatment can become serious quickly. Also tell the team about side effects that are hard to manage, since there are often ways to ease them. Sudden swelling of the face, neck, arms or upper chest with trouble breathing can mean a lymphoma in the chest is pressing on a large vein. This needs emergency care.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with T-Cell Lymphoma is like, what's helped you, or ask the community a question.